The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Statistical analysis of episensitization using transition probability functions and PFS2 for “ROCKET”, a two stage phase II study of RRx-001, a multi-epigenetic agent, investigating resensitization to irinotecan in colorectal cancer.
 
Nacer Abrouk
No Relationships to Disclose
 
Tony R. Reid
No Relationships to Disclose
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Consulting or Advisory Role - Genentech
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Medivation (Inst); Newlink Genetics (Inst); Novartis (Inst); Pharmaceutical Research Associates (Inst); Polaris (Inst); PRA International (Inst); Tercica (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Corey Allan Carter
No Relationships to Disclose
 
Paul M. Thambi
No Relationships to Disclose
 
Bryan Oronsky
No Relationships to Disclose
 
Gary Fanger
No Relationships to Disclose
 
Scott Caroen
No Relationships to Disclose
 
Christopher Parker
No Relationships to Disclose
 
Meaghan Stirn
No Relationships to Disclose
 
Jan Scicinski
No Relationships to Disclose